Canario

Wearable Solution for Monitoring Air Pollution, Viruses, and UV Radiation

Health Tech & Life Sciences
Non Active, Jan 2022 ceased to operate
Follow

Company Overview

Snapshot

Founded in May 2019 by Dovik Barkay, Canario had 1–10 employees. Canario ceased operations in January 2022.

Business overview

Canario develops wearable solutions for monitoring environmental factors to improve health and quality of life. The company's core technology involves a digital nose device that scans the air 24/7, monitoring the environment and alerting users to potential risks. This device measures aerosol droplets, air quality based on the Air Quality Index, and UV radiation, sending real-time reports to a phone application. Canario serves global markets, including the Americas, Central Asia, North America, East Asia, and West Asia, operating within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Medical Decision Support, and Patient Remote Monitoring.

Strategic signal

In January 2021, Canario's technology was highlighted for its potential to protect the public during the pandemic by introducing a personal wearable bio-aerosol real-time sensor. This development indicated the company's focus on immediate public health challenges and its capability to adapt its monitoring solutions to critical global needs, signaling a strong market relevance for its environmental sensing technology.

Log in to access full profile

Company Intelligence Q&A

What is Canario's primary focus?
Canario focuses on improving health and quality of life through reliable, practical air-monitoring solutions, utilizing a digital nose device that scans the air 24/7 for environmental risks.
When was Canario founded?
Canario was founded in May 2019.
What is the status of Canario?
Canario is currently non-active, having ceased operations in January 2022.
What was a key product development for Canario?
In January 2021, Canario introduced a personal wearable bio-aerosol real-time sensor designed to protect the public during the pandemic, capable of warning about Covid droplets.
Log in to access full profile